Dr. Steve Kaldor Joins Furiex Pharmaceuticals, Inc. Board of Directors

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) announced today that Stephen W. Kaldor, Ph.D. has joined its board of directors, bringing over 20 years of biopharmaceutical experience.

MORE ON THIS TOPIC